ClinicalTrials.gg
RecruitingNCT05552547Updated Nov 13, 2026

Home BP Monitoring

An interventional study of Home Blood Pressure Machine and 24-Hour Blood Pressure Machine in High Blood Pressure, sponsored by University Hospitals Cleveland Medical Center. Recruiting at 1 site in United States. Open to participants aged 13 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Oct 2023; still recruiting 3 years 1 month later.
Updated Nov 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
750
Allocation
Non-randomized
Ages
13 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 2,032 studies in Hypertension with a site in United States — 268 open to participants now, 369 under way, 16 of them phase 3. Hypertension · United States.

Planned enrollment
211th of 1,780
750 · median 100
Started
2023
with 100 others
No phase
1,072 of 2,032
168 open now
Primary completion
2027-06
later than 165 of 367 live
Registered
1,623rd of 2,032
by date

Among the 2,032 studies in Hypertension with a site in United States, this one is the 211th largest by planned enrollment of the 1,780 interventional ones that give a count, is one of 101 that started in 2023, is one of 1,072 with no phase, reaches primary completion later than 165 of the 367 other live ones, and was the 1,623rd registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

268 of the 2,032 studies in Hypertension with a site in United States are open now. Recruiting first, the newest first:

263 more — sign in →

All 268 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 13 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,032 studies in Hypertension with a site in United States, or all of them as a file.
02

Study summary

Most cases of high blood pressure in teens are missed for a number of reasons. One reason is that the most common way to make a diagnosis is to make three or more blood pressure measurements in a doctor's office on separate days. This can be inconvenient. Also, measuring blood pressure in the office might be inaccurate, since children (including teens) might have high values in the office but normal values at home. For these reasons, investigators wish to study a different way to identify teens with high blood pressure. Home BP measurements have been used in Europe to make a diagnosis, but not yet in the United States, and never in a higher risk population of teens. African American teens are at higher risk for high blood pressure than other teens. Investigators will compare the values received from the home BP machines to another method (24 hour ambulatory BP monitoring or ABPM) which is the best standard for diagnosis. Investigators also want to learn more about participants experience and their child's experience with both methods. A small sample of participating teens and parents will be invited to participate in short telephone interviews. This study plans to enroll a total of 750 teens at UH. Recruitment will not take place from other organizations.

03

Conditions studied

  • High Blood Pressure

Browse trials for

Keywords

  • African American Teen
  • Home blood pressure monitoring
04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-identify or identified by a parent as African-American or of partly African American ancestry

Exclusion criteria

Exclusion Criteria:

  • Prior hypertension diagnosis
  • Prescribed BP medication
  • History of congenital heart disease
  • History of solid organ transplant
  • Prescribed and using stimulants and other medications on a regular basis known to raise blood pressure such as testosterone and nicotine replacement
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
750 participants (estimated)

Study arms

  • Active comparator
    Home Blood Pressure Machine

    Participants will be asked to measure blood pressure twice daily for three days in a row.

    Device: Home Blood Pressure Machine

  • Experimental
    24-Hour Blood Pressure Machine

    Participants will be asked to wear this machine for 24 hours.

    Device: 24-Hour Blood Pressure Machine

Interventions

  • DeviceHome Blood Pressure Machine

    Participants will be asked to measure blood pressure twice daily for three days in a row at home.

  • Device24-Hour Blood Pressure Machine

    Participants will be asked to wear the machine for 24 hours.

06

What researchers measure

Primary outcomes

  1. Number of participants who meet criteria for hypertension based on average home BP reading.

    Time frame: Up to 2 weeks

  2. Number of participants who meet criteria for hypertension based on 24-hour ambulatory BP reading.

    Time frame: Up to 24 hours

  3. Percent agreement between home BP-reading based diagnosis versus 24-hour ABPM

    Time frame: Up to 2 weeks

  4. True positive rate -- Number of home bp positives over ABPM positives

    Time frame: Up to 2 weeks

  5. True negative rate -- Number of home bp negatives over ABPM negatives

    Time frame: Up to 2 weeks

Secondary outcomes

  1. Number of subjects who complete home BP protocol

    Time frame: Up to 2 weeks

  2. Number of subjects who complete both home BP verus 24-hour ABPM protocols

    Time frame: Up to 3 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Jun 2027, 44 months after the start.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 44 months is above that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Sep 2026 → Jun 2027 and completion Sep 2026 → Jun 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 20, 2022
First posted
Sep 23, 2022
StartActual
Oct 1, 2023
Primary completionEst.
Jun 1, 2027was Sep 2026
CompletionEst.
Jun 1, 2027was Sep 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 30, 2026→Jun 1, 2027
Nov 13, 2026
Study completion
Sep 30, 2026→Jun 1, 2027
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Primary completion Sep 30, 2026→Jun 1, 2027
    Study completion Sep 30, 2026→Jun 1, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05552547
Responsible party
Goutham Rao, MD (Chairman, Department of Family Medicine and Community Health, University Hospitals Cleveland Medical Center) — Principal investigator
First posted
Sep 23, 2022
Start date
Oct 1, 2023
Primary completion
Jun 1, 2027 (estimated)
Completion
Jun 1, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Goutham Rao, MD
Contact
goutham.rao@uhhospitals.org
(216)844-3791
Rao Goutham, MD
principal investigator · University Hospitals Cleveland Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion